[PR Newswire] – RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 2, 2013 /PRNewswire/ — Boehringer Ingelheim and Eli Lilly and Company (LLY) today announced the launch of the largest multinational survey to investigate early conversations between physicians and people living with type 2 diabetes at time of diagnosis and at time of treatment modification. The survey was developed in partnership with the International Diabetes Federation (IDF) and will include more than 10,000 people … [visit site to read more]
Similar posts:- Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Xigduo™ (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
- Stock Update: Merck & Co. Inc. (NYSE:MRK) – Merck announces CHMP Positive Opinion to Update Erbitux Metastatic Colorectal Cancer Labeling to Patients with RAS Wild-type Tumors
- German ZEW survey on tap